policymakers must do more to construct patient-centric measures of the benefits conferred by medical technologies, and permit the patient’s voice to be heard more incisively, both on the input side regarding value assessment, and decision-making side.
Resolving Tension Between Cost-Effectiveness Analysis And Patient Centricity
